ACHV
NASD Achieve Life Sciences, Inc.$8.26 ↑ +0.57 (+7.41%) Trading Up from the previous close of $7.69, $0.02 below the day’s high of $8.28
- YTD change
- +66.20%
- vs 20-day SMA
- +5.95%
- vs 200-day SMA
- +53.08%
Price ranges
Price & Performance
+5.02 (+188.01%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.6% away from all-time highs of $2,035.00
- ACHV is up 66% since the beginning of the year
- ACHV is up 162% over the past 12 months
- ACHV is up 4% over the past 1 month
- 16% of all ACHV investors are betting against ACHV
ACHV reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +144.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.08
- Last 5 days
- +1.72%
- vs 8-day SMA
- +5.24%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.